San Antonio—A new HER-targeted antibody is poised to alter the treatment landscape of patients with HER2-positive metastatic breast cancer.read more
Experts weigh in on the national discussion over the propriety of physician relationships with industry.read more
Critical thinking—like the phrase “evidence-based”—has become a rather overused mantra in clinical medicine. As an unfortunate result, this concept has lost much of its meaning and its impact on how we evaluate study results and ultimately consider their use in the non-trial ...read more
EMMANUEL S. ANTONARAKIS, MD and ANDREW J. ARMSTRONG, MD
This review ...
This review focuses on mucositis affecting the oral cavity, ...
